Physician
Hartford Healthcare Medical Group Specialists, PLLC
Hartford Healthcare Medical Group Specialists, PLLC was paid $46.03M by Medicaid between Jun 2019 and Dec 2024, across 265 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.
33Billing provider infoHARTFORD HEALTHCARE MEDICAL GROUP SPECIALISTS, PLLC
HARTFORD, CT 06106
HARTFORD, CT 06106
33aNPI1023584216assigned 10/16/2018
33bProvider typeTransplant Surgery Physician
28Total paid$46.03M
24GClaims1,476,707
24DCodes billed265
24AFirst – last monthJun 2019 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 65,063 | $1.54M | |
| 2020 | 135,354 | $3.70M | |
| 2021 | 293,822 | $8.95M | |
| 2022 | 323,494 | $10.41M | |
| 2023 | 342,582 | $11.06M | |
| 2024incomplete | 316,392 | $10.37M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 311,208 | 290,006 | $13.44M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 173,933 | 160,193 | $5.57M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 6.2% | 127,058 | 52,689 | $2.87M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.5% | 44,042 | 42,732 | $2.53M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.5% | 31,811 | 30,796 | $2.53M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 4.9% | 4,835 | 2,802 | $2.25M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.3% | 20,518 | 19,492 | $1.52M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 3.3% | 49,970 | 25,690 | $1.52M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3.1% | 29,400 | 28,347 | $1.42M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.3% | 22,483 | 21,188 | $1.08M |
| 99223 | Prolong inpt eval add15 m | 2.0% | 15,844 | 14,938 | $943K |
| 93000 | 2.0% | 107,561 | 100,391 | $917K |
253 more codes
| 99215 | Doctor's office visit, returning patient (complex) | 1.6% | 14,299 | $728K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 1.4% | 39,723 | $639K |
| 99239 | Hospital discharge day management, more than 30 minutes | 1.3% | 18,165 | $613K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 134,749 | $455K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 3,856 | $445K |
| 99283 | Emergency room visit (moderate) | <1% | 12,809 | $407K |
| 99243 | <1% | 5,126 | $389K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 4,956 | $368K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 7,304 | $367K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 7,252 | $309K |
| 43775 | <1% | 587 | $302K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 2,148 | $254K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 11,050 | $191K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 9,805 | $173K |
| 95806 | <1% | 1,797 | $171K | |
| 99205 | Prolong outpt/office vis | <1% | 1,635 | $163K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 3,602 | $153K |
| 99254 | <1% | 1,540 | $135K | |
| 93970 | <1% | 6,746 | $131K | |
| 93926 | <1% | 4,849 | $108K | |
| 51798 | <1% | 18,112 | $104K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 3,426 | $103K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,656 | $101K |
| 93922 | <1% | 3,093 | $93K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 1,671 | $90K |
| 64615 | <1% | 2,340 | $84K | |
| 93971 | <1% | 4,829 | $80K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 923 | $77K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 2,282 | $76K |
| 95720 | <1% | 938 | $75K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 4,090 | $73K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 5,109 | $70K |
| 99245 | <1% | 461 | $60K | |
| 95816 | <1% | 2,489 | $60K | |
| 64400 | <1% | 916 | $60K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,855 | $53K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 9,376 | $52K |
| 11721 | <1% | 8,434 | $51K | |
| 93298 | <1% | 2,781 | $50K | |
| 97597 | <1% | 3,469 | $49K | |
| 99306 | Prolong nursin fac eval 15m | <1% | 896 | $46K |
| 95886 | <1% | 984 | $46K | |
| 90686 | <1% | 3,390 | $45K | |
| 99221 | <1% | 1,130 | $45K | |
| 95251 | <1% | 3,640 | $42K | |
| 93880 | <1% | 1,612 | $42K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 1,109 | $41K |
| 92083 | <1% | 1,064 | $37K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 1,115 | $37K |
| 93458 | <1% | 257 | $30K | |
| 95885 | <1% | 1,050 | $29K | |
| 17110 | <1% | 1,506 | $28K | |
| 76801 | <1% | 680 | $26K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 430 | $26K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 256 | $26K |
| 99242 | <1% | 420 | $25K | |
| 93295 | <1% | 1,314 | $24K | |
| 64405 | <1% | 735 | $24K | |
| 64450 | <1% | 668 | $22K | |
| 93015 | <1% | 550 | $22K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 936 | $22K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 235 | $22K |
| 96127 | <1% | 1,435 | $21K | |
| 94060 | <1% | 1,216 | $21K | |
| 93297 | <1% | 2,146 | $20K | |
| 99443 | <1% | 465 | $20K | |
| 11102 | <1% | 671 | $20K | |
| 94729 | <1% | 1,228 | $20K | |
| 93018 | <1% | 3,135 | $19K | |
| 92133 | <1% | 888 | $19K | |
| 76813 | <1% | 558 | $17K | |
| 95909 | <1% | 312 | $17K | |
| 93294 | <1% | 2,622 | $16K | |
| 52000 | <1% | 335 | $16K | |
| 99255 | <1% | 141 | $15K | |
| 51701 | <1% | 432 | $15K | |
| 99460 | <1% | 322 | $14K | |
| 93225 | <1% | 631 | $14K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 298 | $14K |
| 20610 | <1% | 568 | $14K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 1,359 | $13K |
| 73630 | <1% | 1,050 | $13K | |
| 93016 | <1% | 1,330 | $13K | |
| 99234 | <1% | 231 | $13K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 421 | $13K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 4,103 | $12K |
| 99217 | <1% | 522 | $12K | |
| 11056 | <1% | 1,247 | $11K | |
| 99252 | <1% | 246 | $9K | |
| 99219 | <1% | 278 | $9K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 119 | $9K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 81 | $8K |
| 99442 | <1% | 279 | $8K | |
| 99220 | <1% | 144 | $8K | |
| 94727 | <1% | 476 | $8K | |
| 93227 | <1% | 728 | $8K | |
| 95911 | <1% | 67 | $8K | |
| 81003 | <1% | 34,819 | $7K | |
| 20553 | <1% | 598 | $7K | |
| 46600 | <1% | 210 | $7K | |
| 99152 | <1% | 1,093 | $7K | |
| 94726 | <1% | 481 | $7K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,441 | $7K |
| 20526 | <1% | 185 | $6K | |
| 99241 | <1% | 198 | $6K | |
| 93923 | <1% | 250 | $6K | |
| 92250 | <1% | 177 | $6K | |
| 82947 | <1% | 3,073 | $6K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 216 | $6K |
| 99292 | <1% | 43 | $6K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 108 | $6K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 44 | $5K |
| 95819 | <1% | 190 | $5K | |
| 80061 | Lipid panel | <1% | 665 | $5K |
| 99307 | <1% | 537 | $5K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,234 | $5K |
| 99350 | Prolong home eval add 15m | <1% | 94 | $5K |
| 11055 | <1% | 449 | $5K | |
| 99253 | <1% | 78 | $5K | |
| 99235 | <1% | 60 | $4K | |
| 95913 | <1% | 26 | $4K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,262 | $4K |
| 93793 | <1% | 987 | $4K | |
| 90662 | <1% | 437 | $4K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 198 | $4K |
| 64721 | <1% | 18 | $3K | |
| 43235 | <1% | 52 | $3K | |
| 76830 | Ultrasound, transvaginal | <1% | 165 | $3K |
| 99224 | <1% | 181 | $3K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 95 | $3K |
| 27096 | <1% | 28 | $3K | |
| 93296 | <1% | 402 | $3K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 83 | $3K |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 25 | $3K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 565 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 260 | $3K |
| 80053 | Comprehensive metabolic panel | <1% | 457 | $3K |
| 0124A | <1% | 103 | $3K | |
| 99401 | <1% | 67 | $2K | |
| 95250 | <1% | 59 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 270 | $2K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 86 | $2K |
| 64483 | <1% | 12 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 219 | $2K |
| 64616 | <1% | 78 | $2K | |
| 99225 | <1% | 95 | $2K | |
| 51797 | <1% | 25 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,454 | $2K |
| 51728 | <1% | 25 | $2K | |
| 11104 | <1% | 33 | $2K | |
| 73620 | <1% | 165 | $2K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 86 | $2K |
| 51741 | <1% | 107 | $2K | |
| 95910 | <1% | 28 | $2K | |
| 94618 | <1% | 156 | $2K | |
| 94010 | <1% | 117 | $2K | |
| 93356 | <1% | 305 | $2K | |
| 99385 | <1% | 24 | $2K | |
| 90674 | <1% | 71 | $1K | |
| 92587 | <1% | 62 | $1K | |
| 76376 | <1% | 251 | $1K | |
| 93272 | <1% | 96 | $1K | |
| 81002 | <1% | 10,328 | $1K | |
| 95822 | <1% | 62 | $1K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 12 | $1K |
| 90715 | <1% | 41 | $1K | |
| 0064A | <1% | 34 | $1K | |
| 20550 | <1% | 60 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 454 | $1K |
| 76536 | <1% | 40 | $1K | |
| 91320 | <1% | 14 | $1K | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 260 | $998.76 |
| 99305 | <1% | 13 | $988.11 | |
| 90837 | Psychotherapy session, about an hour | <1% | 18 | $983.20 |
| 93280 | <1% | 104 | $949.62 | |
| 99310 | Prolong nursin fac eval 15m | <1% | 15 | $908.55 |
| 97810 | <1% | 93 | $897.60 | |
| 95012 | <1% | 132 | $871.50 | |
| 73562 | <1% | 61 | $869.84 | |
| 78431 | <1% | 33 | $857.55 | |
| 51784 | <1% | 27 | $857.11 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 219 | $795.70 |
| 99497 | <1% | 122 | $784.79 | |
| 93264 | <1% | 111 | $783.90 | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 13 | $774.41 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 81 | $762.24 |
| 20605 | <1% | 45 | $760.40 | |
| 52287 | <1% | 34 | $725.52 | |
| 98968 | <1% | 19 | $671.40 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 68 | $658.92 |
| 76883 | <1% | 12 | $612.44 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 12 | $564.41 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 168 | $541.70 |
| 11720 | <1% | 99 | $520.18 | |
| 95874 | <1% | 118 | $516.48 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 46 | $507.12 |
| 17000 | <1% | 71 | $476.44 | |
| 99318 | <1% | 14 | $466.69 | |
| 99451 | <1% | 127 | $428.00 | |
| 72084 | <1% | 14 | $425.15 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 17 | $395.75 |
| 11900 | <1% | 68 | $377.44 | |
| 72082 | <1% | 13 | $357.72 | |
| 93290 | <1% | 73 | $355.01 | |
| 93308 | <1% | 32 | $354.06 | |
| 99462 | <1% | 18 | $326.76 | |
| 85610 | <1% | 134 | $292.83 | |
| 99336 | <1% | 74 | $282.70 | |
| 0054A | <1% | 28 | $280.00 | |
| 99173 | <1% | 49 | $228.00 | |
| 74420 | <1% | 29 | $215.20 | |
| 91040 | <1% | 12 | $208.39 | |
| 93284 | <1% | 13 | $195.45 | |
| G0127 | Trimming of dystrophic nails, any number | <1% | 116 | $172.14 |
| 90656 | <1% | 205 | $156.45 | |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 13 | $152.50 |
| 92202 | <1% | 18 | $149.10 | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 62 | $115.08 |
| 93288 | <1% | 12 | $111.88 | |
| 36416 | <1% | 33 | $93.69 | |
| 93244 | <1% | 12 | $90.12 | |
| 99315 | <1% | 15 | $63.50 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 42 | $47.36 |
| 80050 | General health panel | <1% | 67 | $36.90 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 31 | $28.99 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 17 | $23.19 |
| 97803 | <1% | 105 | $20.95 | |
| G0008 | Administration of influenza virus vaccine | <1% | 717 | $18.34 |
| 85027 | <1% | 24 | $13.36 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 17 | $7.86 |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | <1% | 91 | $7.79 |
| 82962 | <1% | 17 | $6.06 | |
| 82044 | <1% | 14 | $4.37 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 344 | $3.25 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 17 | $2.81 |
| 3078F | 0% | 12,692 | $0.00 | |
| 3077F | 0% | 2,346 | $0.00 | |
| 91312 | 0% | 103 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 28 | $0.00 |
| 91300 | 0% | 69 | $0.00 | |
| 64999 | 0% | 17 | $0.00 | |
| 3051F | 0% | 13 | $0.00 | |
| 3074F | 0% | 10,363 | $0.00 | |
| 3075F | 0% | 5,451 | $0.00 | |
| 3079F | 0% | 8,602 | $0.00 | |
| 3044F | 0% | 333 | $0.00 | |
| 3080F | 0% | 217 | $0.00 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 0% | 27 | $0.00 |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 125 | $0.00 |
| 91305 | 0% | 67 | $0.00 | |
| 99000 | 0% | 15 | $0.00 | |
| 97802 | 0% | 12 | $0.00 | |
| 91306 | 0% | 34 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVYE, MARK (VP ADMINISTRATION)